2Qualman SJ, Coffin CM, Newton WA, et al. Intergroup rhabdomyo- sacraoma : Update for pathologist [ J ]. Pediatr Dev Pathol, 1998,1 (6) :550 -561.
3I-Ierzog CE. Overview of sarcomas in the adolescent and young adult population [ J ]. J Pediat Hemato1,2005,27 (4) :215 - 218.
4Flecher CDM, Unni KK, Mertens F. Pathology and genetics of tumours of soft tissue and bone [ M ]. Lyon : IARC Press,2002 : 11.
5黄福光,潘尹.胚胎性横纹肌肉瘤的超声表现[J].中国超声医学杂志,1998,14(4):60.
6Walterhouse D, Watson A, Optimal management strategies for rhab- domyosarcoma in children[ J ]. Paediatric Drugs, 2007,9 ( 6 ) : 391 - 400.
7Hermans BP, Foster RS, Bihrle R, et al. Is retroperitoneal lymph node dissection necessary for adult paratesticular rhabdomyosarco- ma[J] ? J Uro1,1998,160(6 Ptl ) :2074 -2077.
8Raney RB, Maurer HM, Anderson JR, et al. The Intergroup Rhab- domyosarcoma Study Group (IRSG) :Major lessons from the IRS - Ⅰ through IRS - IV studies as background for the current IRS - V treatment protocols[ J]. Sarcoma ,2001,5 ( 1 ) :9 - 15.
9Stewart R J, Martelli H, Oberlin O, et al. Treatment of children with nonmetastatic paratesticular rhabdomyosareoma: results of the Ma- lignant Mesenchymal Tumors Studies ( MMT 84 and MMT 89) of the International Society of Pediatric Ontology [ J ]. J Clin Oneol, 2003,21(5) :793 - 798.
10Wolden SL, Anderson JR, Crist WM, et al. Indications for radio- therapy and chemotherapy after complete resection in rhabdomyo- sarcoma : a report from the Intergroup Rhabdomyosarcoma Studies Ⅰ to Ⅲ [ J]. J Clin Oncol, 1999,17 ( 11 ) :3468 - 3475.
